Biotech Values

[pollyvonwog]

So per my shoddy math ABBV seems to have locked up a solid 33-35% of the hcv population in preferred deals, no?

ESRX = 8-10%
co-infected HIV/HCV population = 10%
Medicaid deal = 15% (Using Merrill 30% number as baseline here).